E

Exelixis

Biopharmaceutical oncology company developing cancer therapies

Clinical Development Medical Director

Clinical Research OperationsUpdated on Nov 10
Full-timeRemote in USARemote

About the Job

Requirements

  • A Doctor of Medicine degree is required, with a minimum of five years of post-residency experience.
  • Drug development experience in the biotechnology or pharmaceutical industry, or a combination of academia and industry, is required; extensive academic experience without pharmaceutical industry experience may be considered.
  • Hands-on experience in the design, execution, and reporting of controlled clinical trials in oncology is required.
  • Experience participating in clinical oncology studies involving molecular targeted or immunological therapies is required.
  • Understanding of basic science relevant to clinical oncology, including biochemistry, immunology, molecular biology, and/or genetics, is required.
  • Ability to work effectively in a cross-functional or matrix environment is required.
  • Ability to develop technical and/or business solutions to complex problems and implement methods, techniques, procedures, and evaluation criteria is required.
  • Ability to develop and maintain relationships with significant key opinion leaders is required.
  • Strong interpersonal, influencing, presentation, written, and verbal communication skills are required.
  • Strong organizational and time management skills are required.

Responsibilities

  • Lead and execute early- and late-stage clinical trials for oncology products in development in collaboration with clinical teams.
  • Participate in clinical study design and planning, and help interpret study results.
  • Establish and approve scientific methods for designing and implementing clinical protocols, data collection systems, and final reports.
  • Recruit clinical investigators for research studies as needed.
  • Report adverse events and monitor safety responsibilities.
  • Monitor adherence to protocols and determine study completion.
  • Design, prepare, and initiate study protocols and required documentation in compliance with project plans, federal regulations, Good Clinical Practice, and good medical practice.
  • Act as medical monitor for company-sponsored trials.
  • Support project teams with therapeutic-area-specific information.
  • Collaborate with the internal safety group to analyze and report clinical-trial safety data.
  • Analyze and interpret other clinical-trial data and prepare reports for regulatory agencies and publication.
  • Interact with key opinion leaders and investigators in the relevant disease-specific area.
  • Ensure consistency of scientific and development strategies for oncology products in development.
  • Maintain a high level of scientific and clinical knowledge in the relevant disease-specific area.
  • Work on complex problems requiring in-depth evaluation of multiple factors and on abstract problems across business functions.
  • Exercise independent judgment in methods, techniques, and evaluation criteria for obtaining results.
  • Interact regularly with executives and/or major customers.

Desired Qualifications

  • Board certification or eligibility in Oncology or Hematology/Oncology is desirable but not essential.

About the Company

Exelixis

Biopharmaceutical oncology company developing cancer therapies

Exelixis develops and commercializes medicines for cancer. Its products aim to treat advanced cancers, including renal cell carcinoma, by targeting multiple biological pathways and supporting combination regimens to achieve effective, tolerable, and durable responses. The company generates revenue from sales of approved therapies and strategic partnerships, backed by extensive research, clinical trials, and regulatory approvals to bring new drugs to market. Compared with peers, Exelixis focuses on a pipeline that combines multi-pathway targeting with combination therapies to improve patient outcomes. Its overall goal is to advance cancer treatment and offer patients better chances of remission through its ongoing drug development programs.

Company size
1,001-5,000
Company stage
IPO
Headquarters
San Francisco, CA
Founded
1994

Recently Posted Jobs

Explore more opportunities at Exelixis

See more jobs